These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 26429605)
21. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia. Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant]. Lepe JA; Gil-Navarro MV; Santos-Rubio MD; Bautista J; Aznar J Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023 [TBL] [Abstract][Full Text] [Related]
23. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia. Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565 [TBL] [Abstract][Full Text] [Related]
24. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough? Lodise TP; Drusano GL; Zasowski E; Dihmess A; Lazariu V; Cosler L; McNutt LA Clin Infect Dis; 2014 Sep; 59(5):666-75. PubMed ID: 24867791 [TBL] [Abstract][Full Text] [Related]
26. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid. Hamilton LA; Christopher Wood G; Magnotti LJ; Croce MA; Martin JB; Swanson JM; Boucher BA; Fabian TC J Trauma Acute Care Surg; 2012 Jun; 72(6):1478-83. PubMed ID: 22695410 [TBL] [Abstract][Full Text] [Related]
27. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575 [TBL] [Abstract][Full Text] [Related]
28. Continuous infusion vancomycin for treatment of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients. Fung L Ann Pharmacother; 2012 Oct; 46(10):e26. PubMed ID: 23032658 [TBL] [Abstract][Full Text] [Related]
29. Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis. Steinmetz T; Eliakim-Raz N; Goldberg E; Leibovici L; Yahav D Clin Microbiol Infect; 2015 Jul; 21(7):665-73. PubMed ID: 25887712 [TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
31. Modified vancomycin dosing protocol for treatment of diabetic foot infections. Niu SC; Deng ST; Lee MH; Ho C; Chang HY; Liu FH Am J Health Syst Pharm; 2008 Sep; 65(18):1740-3. PubMed ID: 18769001 [TBL] [Abstract][Full Text] [Related]
32. Innovative approaches to optimizing the delivery of vancomycin in individual patients. Pai MP; Neely M; Rodvold KA; Lodise TP Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345 [TBL] [Abstract][Full Text] [Related]
33. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455. Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818 [TBL] [Abstract][Full Text] [Related]
35. [The change and significance of vancomycin minimal inhibitory concentration against methicillin-resistant Staphylococcus aureus isolates from inpatients with lower respiratory tract infection]. Yang W; He B; Ning YZ; Li Y Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):288-92. PubMed ID: 23945344 [TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy. Moffett BS; Morris J; Munoz F; Arikan AA Eur J Clin Pharmacol; 2019 Aug; 75(8):1089-1097. PubMed ID: 30937470 [TBL] [Abstract][Full Text] [Related]
39. The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients. Cheong JY; Makmor-Bakry M; Lau CL; Abdul Rahman R S Afr Med J; 2012 May; 102(7):616-9. PubMed ID: 22748440 [TBL] [Abstract][Full Text] [Related]
40. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients. Morrill HJ; Caffrey AR; Noh E; LaPlante KL Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]